21583 ⎘
Preparations containing radioactive substances for use in therapy or testing characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus; Organic compounds; Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins; Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against material from bacteria
Anti-C3d antibody conjugates and methods of detecting complement activation
#2Monoclonal antibodies that neutralize anthrax toxins
#3Light-emitting versions of the monoclonal antibody to C3D (MAB 3D29) for imaging
#4Monoclonal antibodies that neutralize anthrax toxins
#5Human Monoclonal Antibodies Against Hendra and Nipah Viruses
#6Monoclonal antibodies that neutralize anthrax toxins
#7Human monoclonal antibodies against protective antigen
#8Human monoclonal antibodies against hendra and nipah viruses
#9Monoclonal antibodies that neutralize anthrax toxins
#10Human monoclonal antibodies against Hendra and Nipah viruses
#11STREPTAVIDIN-BIOTIN-LINK ANTIBODY-HAPTEN SYSTEM
#12Human monoclonal antibodies against protective antigen
#13Imaging the activity of extracellular protease in cells using mutant anthrax toxin protective antigens that are cleaved by specific extracellular proteases
#14Synthetic anti-plague antibodies
#15Method for targeting antigens unique to a tumor